DBT
ITCI icon

Dubuque Bank & Trust’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Dubuque Bank & Trust’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-250
Closed -$3K – 627
2019
Q1 		$3K Hold
250
– – ﹤0.01% 636
2018
Q4 		$3K Hold
250
– – ﹤0.01% 568
2018
Q3 		$5K Hold
250
– – ﹤0.01% 513
2018
Q2 		$4K Hold
250
– – ﹤0.01% 561
2018
Q1 		$5K Hold
250
– – ﹤0.01% 576
2017
Q4 		$4K Hold
250
– – ﹤0.01% 597
2017
Q3 		$4K Buy
+250
New +$3.67K ﹤0.01% 574
2016
Q3 		– Sell
-250
Closed -$10K – 599
2016
Q2 		$10K Buy
+250
New +$8.98K ﹤0.01% 430

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SC
Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return

Dubuque Bank & Trust's ITCI Position: Q2 2019 in Review

Dubuque Bank & Trust sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2019, closing a stake of 250 shares — an estimated $3K sold.

Dubuque Bank & Trust first reported a position in ITCI in Q2 2016 and held it in 8 quarters. The position peaked at $10K in Q2 2016. 126 funds tracked by Wall St. Rank hold ITCI as of Q2 2019.

  • Dubuque Bank & Trust reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2019 after selling out during the quarter.
  • Dubuque Bank & Trust sold 250 Intra-Cellular Therapies Inc. shares in Q2 2019, an estimated $3K.
  • Dubuque Bank & Trust first reported a position in Intra-Cellular Therapies Inc. in Q2 2016 and held it in 8 quarters.
  • Dubuque Bank & Trust's Intra-Cellular Therapies Inc. position peaked at $10K in Q2 2016.
  • 126 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2019.

Based on Dubuque Bank & Trust's 13F filing for Q2 2019, filed 10 Jul 2019.